{"id":"W4390918445","doi":"10.1186/s13063-023-07834-8","title":"Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET","year":2024,"lang":"en","type":"article","venue":"Trials","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lanreotide; Tolerability; Octreotide; Internal medicine; Clinical trial; Dosing; Neuroendocrine tumors; Somatostatin; Gastroenterology; Adverse effect; Oncology; Surgery; Acromegaly","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005944236,0.002841883,0.002870364,0.0005090223,0.0005535661,0.00177346,0.0014234,0.002604645,0.01202065],"category_scores_gemma":[0.004410082,0.0008895946,0.002905887,0.0004713853,0.001839731,0.001493508,0.0006719877,0.003759328,0.002088867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007883981,"about_ca_system_score_gemma":0.002963488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000444534,"about_ca_topic_score_gemma":0.0008102807,"domain_scores_codex":[0.996769,0.002080275,0.0001183749,0.0004243181,0.0002643312,0.0003437732],"domain_scores_gemma":[0.9982151,0.0004505243,0.000412524,0.0001842059,0.0001383882,0.0005993192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9793152,0.004608537,0.0006480743,0.0009768608,0.0005052271,0.00007893685,0.00007869595,0.000353372,0.002574348,0.000584418,0.001634732,0.008641625],"study_design_scores_gemma":[0.9628039,0.03422607,0.0006991156,0.00004889971,0.0002024692,0.00002748456,0.00001335313,0.0002257785,0.0001882172,0.000212594,0.001339246,0.00001284886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.8119357,0.009180549,0.005810211,0.004120576,0.003193805,0.138829,0.00617048,0.0004980994,0.02026172],"genre_scores_gemma":[0.8069666,0.003464489,0.01376659,0.005428459,0.001570719,0.1512213,0.004156162,0.0001344357,0.01329129],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01202065,"threshold_uncertainty_score":0.04021305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.130178862475752,"score_gpt":0.4812644040670503,"score_spread":0.3510855415912983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}